Security key
78667J108
Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (SAGE)
CUSIP: 78667J108
Q2 2024 13F Holders as of 30 Jun 2024
- Security type / class
- Equity / Common Stock, par value $0.0001 per share (the "Common Stock")
- Total 13F shares
- 53,511,146
- Total 13F value
- $581,112,272
- Share change
- -4,750,626
- Put/Call ratio
- 24%
- SEC-reported price per share
- $10.86
- Number of holders
- 190
- Value change
- -$70,089,721
- Number of buys
- 105
- Number of sells
- 92
- Shares outstanding
- 62,650,155
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2024
Institutions
190
Top holders
10
SAGE full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q4 2025
Sage Therapeutics, Inc. SEC filings
Sage Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 78667J108
Recent filing periods:
Ownership snapshot
Top reported holders of SAGE - Sage Therapeutics, Inc. - Common Stock, par value $0.0001 per share (the "Common Stock") (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
FMR LLC
Disclosed value leader
FMR LLC
Comparable rows
15/15
Latest evidence
31 Mar 2024
13F
Lead comparable stake: 9.4%
Showing 1-6 of 15 holder rows.
Quick read
FMR LLC leads the comparable SEC ownership view at 9.4%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens FMR LLC's linked filing trail.
Comparable ownership
Top 5
FMR LLC
9.4%
VANGUARD GROUP INC
9.2%
RTW INVESTMENTS, LP
8.7%
BlackRock Finance, Inc.
7.8%
WELLINGTON MANAGEMENT GROUP LLP
7.6%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| FMR LLC |
13F
Company
|
9.4%
|
$109,971,623
5,868,283 shares
|
— | 31 Mar 2024 |
| VANGUARD GROUP INC |
13F
Company
|
9.2%
|
$107,780,730
5,751,373 shares
|
— | 31 Mar 2024 |
| RTW INVESTMENTS, LP |
13F
Company
|
8.7%
|
$102,706,013
5,480,577 shares
|
— | 31 Mar 2024 |
| BlackRock Finance, Inc. |
13F
Company
|
7.8%
|
$91,679,115
4,892,162 shares
|
— | 31 Mar 2024 |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
Company
|
7.6%
|
$89,056,171
4,752,197 shares
|
— | 31 Mar 2024 |
| STATE STREET CORP |
13F
Company
|
7.2%
|
$84,232,477
4,494,796 shares
|
— | 31 Mar 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
190
Shares
53,511,146
Rows available
190
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2024 vs Q4 2025 Across Filers
Q4 2025 holders
2
Q2 2024 holders
190
Holder diff
188
| Investor | Q4 2025 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q4 2025 value | Q2 2024 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend